{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:18:11Z","timestamp":1782940691209,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T00:00:00Z","timestamp":1721520000000},"content-version":"am","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010523","name":"Centre for Addiction and Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010523","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jad.2023.07.049","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T11:13:43Z","timestamp":1689592423000},"page":"691-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR*D analysis"],"prefix":"10.1016","volume":"339","author":[{"given":"Victor M.","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengdeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory R.","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett D.M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Blumberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafiris J.","family":"Daskalakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Voineskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2023.07.049_bb0005","first-page":"CD008581","article-title":"Antidepressants for the treatment of people with co-occurring depression and alcohol dependence","volume":"4","author":"Agabio","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.jad.2023.07.049_bb0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/hup.935","article-title":"Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study","volume":"23","author":"Altintoprak","year":"2008","journal-title":"Hum. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jad.2023.07.049_bb0015","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.comppsych.2013.10.007","article-title":"Comorbidity between major depression and alcohol use disorder from adolescence to adulthood","volume":"55","author":"Bri\u00e8re","year":"2014","journal-title":"Compr. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2023.07.049_bb0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1037\/0022-006X.65.5.715","article-title":"Cognitive-behavioral treatment for depression in alcoholism","volume":"65","author":"Brown","year":"1997","journal-title":"J. Consult. Clin. Psychol."},{"issue":"1","key":"10.1016\/j.jad.2023.07.049_bb0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1176\/ajp.152.1.45","article-title":"Alcoholism and affective disorder: clinical course of depressive symptoms","volume":"152","author":"Brown","year":"1995","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2023.07.049_bb0030","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S2215-0366(19)30222-6","article-title":"Psychiatric comorbidities in alcohol use disorder","volume":"6","author":"Castillo-Carniglia","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2023.07.049_bb0035","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.psychres.2016.06.005","article-title":"Mirtazapine in comorbid major depression and an alcohol use disorder: a double-blind placebo-controlled pilot trial","volume":"242","author":"Cornelius","year":"2016","journal-title":"Psychiatry Res."},{"issue":"2\u20133","key":"10.1016\/j.jad.2023.07.049_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.drugalcdep.2009.10.003","article-title":"Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes","volume":"107","author":"Davis","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.jad.2023.07.049_bb0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/da.20918","article-title":"Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial","volume":"29","author":"Davis","year":"2012","journal-title":"Depress. Anxiety"},{"issue":"12","key":"10.1016\/j.jad.2023.07.049_bb0050","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1001\/jama.1989.03430120100029","article-title":"Lithium treatment of depressed and nondepressed alcoholics","volume":"262","author":"Dorus","year":"1989","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jad.2023.07.049_bb0055","doi-asserted-by":"crossref","first-page":"e1291","DOI":"10.4088\/JCP.17m11448","article-title":"Clinical and genetic predictors of delayed remission after multiple levels of antidepressant treatment: toward early identification of depressed individuals for advanced care options","volume":"78","author":"Falola","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2023.07.049_bb0060","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0193-953X(02)00107-7","article-title":"Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study","volume":"26","author":"Fava","year":"2003","journal-title":"Psychiatr. Clin. North Am."},{"issue":"5","key":"10.1016\/j.jad.2023.07.049_bb0065","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13637","article-title":"Survival probabilities and predictors of major depressive episode incidence among individuals with various types of substance use disorders","volume":"82","author":"Hassan","year":"2021","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2023.07.049_bb0070","doi-asserted-by":"crossref","first-page":"503","DOI":"10.15288\/jsad.2007.68.503","article-title":"Substance use-disorder treatment and a decline in attempted suicide during and after treatment","volume":"68","author":"Ilgen","year":"2007","journal-title":"J. Stud. Alcohol Drugs."},{"issue":"7","key":"10.1016\/j.jad.2023.07.049_bb0075","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/da.22045","article-title":"Predictive socioeconomic and clinical profiles of antidepressant response and remission","volume":"30","author":"Jain","year":"2013","journal-title":"Depress. Anxiety."},{"issue":"1","key":"10.1016\/j.jad.2023.07.049_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.jcp.0000194620.61868.35","article-title":"Sertraline treatment of co-occurring alcohol dependence and major depression","volume":"26","author":"Kranzler","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jad.2023.07.049_bb0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/070674371205700603","article-title":"Pharmacotherapy of alcohol use disorders and concurrent psychiatric disorders: a review","volume":"57","author":"Lev-Ran","year":"2012","journal-title":"Can. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.jad.2023.07.049_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pnpbp.2004.10.005","article-title":"Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification","volume":"29","author":"Liappas","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2023.07.049_bb0095","article-title":"Cognitive-behavioral interventions targeting alcohol or other drug use and co-occurring mental health disorders: a meta-analysis","author":"Mehta","year":"2021","journal-title":"Alcohol Alcohol."},{"issue":"6","key":"10.1016\/j.jad.2023.07.049_bb0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/01.jcp.0000095346.32154.41","article-title":"Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial","volume":"23","author":"Moak","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2023.07.049_bb0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jad.2018.09.067","article-title":"A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder","volume":"243","author":"Perlman","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.jad.2023.07.049_bb0110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1176\/appi.ajp.2009.08060852","article-title":"A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence","volume":"167","author":"Pettinati","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2023.07.049_bb0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0197-2456(03)00112-0","article-title":"Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design","volume":"25","author":"Rush","year":"2004","journal-title":"Control. Clin. Trials"},{"issue":"4","key":"10.1016\/j.jad.2023.07.049_bb0120","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/da.23135","article-title":"Treatment-resistant major depressive disorder: Canadian expert consensus on definition and assessment","volume":"38","author":"Rybak","year":"2021","journal-title":"Depress. Anxiety."},{"issue":"2","key":"10.1016\/j.jad.2023.07.049_bb0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1037\/1082-989X.7.2.147","article-title":"Missing data: our view of the state of the art","volume":"7","author":"Schafer","year":"2002","journal-title":"Psychol. Methods"},{"issue":"11","key":"10.1016\/j.jad.2023.07.049_bb0130","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/0706743720915420","article-title":"Pharmacological treatment of mood disorders and comorbid addictions: a systematic review and meta-analysis: Traitement Pharmacologique des Troubles de L\u2019humeur et des D\u00e9pendances Comorbides: Une Revue Syst\u00e9matique et une M\u00e9ta-Analyse","volume":"65","author":"Stokes","year":"2020","journal-title":"Can. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.jad.2023.07.049_bb0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2023.07.049_bb0140","first-page":"1","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"Van Buuren","year":"2011","journal-title":"J. Stat. Softw."},{"issue":"6","key":"10.1016\/j.jad.2023.07.049_bb0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11920-007-0061-3","article-title":"The STAR*D Project results: a comprehensive review of findings","volume":"9","author":"Warden","year":"2007","journal-title":"Curr. Psychiatry. Rep."},{"issue":"8","key":"10.1016\/j.jad.2023.07.049_bb0150","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archpsyc.58.8.787","article-title":"A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire","volume":"58","author":"Zimmerman","year":"2001","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723008819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723008819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:22:06Z","timestamp":1777494126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032723008819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":30,"alternative-id":["S0165032723008819"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2023.07.049","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR*D analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2023.07.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}